BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27346824)

  • 1. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.
    Le YL; McFall SL; Byrd TL; Volk RJ; Cantor SB; Kuban DA; Mullen PD
    Narrat Inq Bioeth; 2016; 6(1):51-61. PubMed ID: 27346824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
    Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
    Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
    Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
    J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
    Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
    J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
    Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
    BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From "death sentence" to "good cancer": couples' transformation of a prostate cancer diagnosis.
    Maliski SL; Heilemann MV; McCorkle R
    Nurs Res; 2002; 51(6):391-7. PubMed ID: 12464759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partner's influence on patient preference for treatment in early prostate cancer.
    Srirangam SJ; Pearson E; Grose C; Brown SC; Collins GN; O'Reilly PH
    BJU Int; 2003 Sep; 92(4):365-9. PubMed ID: 12930420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer.
    McIntosh M; Opozda MJ; Short CE; Galvão DA; Tutino R; Diefenbach M; Ehdaie B; Nelson C
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13697. PubMed ID: 36138320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
    Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
    BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.
    Bayliss D; Duff J; Stricker P; Walker K
    Urol Nurs; 2016; 36(3):141-9. PubMed ID: 27501595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of couple agreement in U.S. fertility decisions.
    Williams LB
    Fam Plann Perspect; 1994; 26(4):169-73. PubMed ID: 7957819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
    Bayliss DR; Duff J; Stricker P; Walker K
    Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of prostate cancer on partners: a qualitative exploration.
    Wootten AC; Abbott JM; Osborne D; Austin DW; Klein B; Costello AJ; Murphy DG
    Psychooncology; 2014 Nov; 23(11):1252-8. PubMed ID: 24764291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The participation experiences of localized prostate cancer patients in the treatment decision-making process].
    Chien CH; Chuang CK; Liu KL; Liu HE
    Hu Li Za Zhi; 2007 Feb; 54(1):35-42. PubMed ID: 17340546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.